GERN Stock | News | Quote | Stock Forum | Friday, November 8,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$GERN Geron Corp. GERN Company Overview 

Geron Corp. GERN Current Price and Quotes
Last Price 5.21
Previous Close 3.60 Open 7.25
Daily Range 7.79 - 5.18 52wk Range 4.78 - 0.91
Volume 48,495,712 Dividend N/A
Average Vol (3m) 2,459,164 Yield N/A

GERN Stock Message Board http://investorshangout.com/search?q=GERN&...mp;yt1=Go!

Last Updated: Friday, November 8, 2013 01:49:49 AM

Geron Corp. GERN
Company Information

230 Constitution Drive
Menlo Park, CA 94025

Phone: (650) 473-7700

Geron Corp. GERN
Not Available

Geron Corp. GERN
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Latest Report Sep 30, 2013 10-Q
CIK 0000886744
Fiscal Year End 12/31
OTC Marketplace Not Available
Profile Data

SIC - Industry Classification Not Available
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Geron Corp. GERN
GERN Security Details

Share Structure

Market Value1 $533,894,919 a/o Nov 07, 2013
Shares Outstanding 128,649,378 a/o Aug 01, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 857 a/o Feb 28, 2008
Security Notes

New Issue=7-96 2,000,000 shs at $8 by J.P. Morgan & Co. et al.
Short Selling Data

Short Interest 15,185,251 (3.78%)
Nov 30, 2010
Significant Failures to Deliver  No
Transfer Agent(s)

Computershare Trust Company Inc.

Geron Corp. GERN Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 2,709 2,438 3,563 1,726
Cost of Revenue - - - -
Gross Profit 2,709 2,438 3,563 1,726
Operating Expenses

Research and Development 51,368 69,316 61,687 57,617
Sales, General and Admin. 20,397 23,789 18,043 14,343
Non-Recurring Items 2,702 5,449 35,000 -
Other - - - -
Operating Income (71,758) (96,116) (111,167) (70,234)
Income From Continuing Operations

Add'l Income/Expense Items 3,110 3 2,235 1,531
Earnings Before Interest and Tax (68,648) (94,449) (108,932) (68,703)
Interest Expense 233 237 98 143
Earnings Before Tax (68,881) (94,686) (109,030) (68,846)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - (503) (2,347) (1,338)
Net Income Cont. Operations (68,881) (96,853) (111,377) (70,184)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (68,881) (96,853) (111,377) (70,184)
Preferred Stock and Other Adjustments - - - (190)
Net Income Applicable to Common Shareholders (68,881) (96,853) (111,377) (70,374)

Geron Corp. GERN Recent News

Nov 7, 2013 Geron Corporation Reports Third Quarter 2013 Financial Results
Nov 7, 2013 WIN, VNDA, BIOS, GERN added to NASDAQ Active Stock Watch List at GSR
Nov 1, 2013 Geron Announces Conference Call to Discuss Third Quarter 2013 Financial Results
Oct 31, 2013 Pre-Market Review: Arena Pharma Inc., Geron Corp., Incyte Corp. Ltd, and Spectrum Pharma Inc.
Oct 21, 2013 Divestiture, Clinical Study Updates, New Drug Application, and Quarterly Report - Research Report on Geron, NPS, Portola, MannKind, and Exact Sciences
Oct 8, 2013 Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp.
Oct 1, 2013 TSLA, AGNC, GERN and ZLCS added to Nasdaq Active Stock Watch List at GSR
Oct 1, 2013 Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron's Embryonic Stem Cell Assets
Oct 1, 2013 Geron Completes Divestiture of Stem Cell Assets
Sep 24, 2013 FSLR, LINE, GERN and CLDX added to NASDAQ Active Stock Watch List at EPR

1
2
next >

GERN Geron Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GERN&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GERN/quote
Stock Chart http://www.otcmarkets.com/stock/GERN/chart
Company Info http://www.otcmarkets.com/stock/GERN/company-info
Recent News http://www.otcmarkets.com/stock/GERN/news
Financials http://www.otcmarkets.com/stock/GERN/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GERN/filings
Short Sales http://www.otcmarkets.com/stock/GERN/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GERN/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GERN/research
Summary http://finance.yahoo.com/q?s=GERN
Historical Prices http://finance.yahoo.com/q/hp?s=GERN+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GERN
Basic Chart http://finance.yahoo.com/q/bc?s=GERN+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GERN+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GERN+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GERN+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GERN+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GERN+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GERN+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GERN+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GERN+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GERN+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GERN
Balance Sheet http://finance.yahoo.com/q/bs?s=GERN
Cash Flow http://finance.yahoo.com/q/cf?s=GERN+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GERN
Market Watch http://www.marketwatch.com/investing/stock/GERN
Bloomberg http://www.bloomberg.com/quote/GERN:US
Morningstar http://quotes.morningstar.com/stock/s?t=GERN
Bussinessweek http://investing.businessweek.com/research/st...icker=GERN
Barchart http://www.barchart.com/quotes/stocks/GERN
OTC Short Report http://otcshortreport.com/index.php?index=GERN
Investopedia http://www.investopedia.com/markets/stocks/GERN/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading